Skip to main content
Indietro

Hemostasis and Related Disorders: Mechanisms, Disorders, and Laboratory Assessment

Guida di studio - Note intelligenti

Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.

Hemostasis: Overview

Definition and Phases of Hemostasis

Hemostasis is the physiological process that stops bleeding at the site of vascular injury. It involves a complex interplay of cellular and molecular mechanisms to maintain blood fluidity and prevent excessive blood loss.

  • Vasoconstriction: Immediate narrowing of blood vessels to reduce blood flow.

  • Platelet Plug Formation: Platelets adhere to the site of injury and aggregate to form a temporary plug.

  • Coagulation: Activation of clotting factors leads to the formation of a stable fibrin clot.

  • Clot Retraction and Dissolution: The clot contracts and is eventually dissolved as healing occurs.

Key Terms: Hemostasis, vasoconstriction, platelet plug, coagulation, fibrin, clot retraction, clot dissolution.

Phases of Hemostasis

Vasoconstriction

Vasoconstriction is the initial response to vessel injury, reducing local blood flow and minimizing blood loss.

  • Mediators: Thromboxane A2 (TXA2) from platelets, endothelin-1, epinephrine, and norepinephrine.

  • Mechanism: These mediators act on vascular smooth muscle to induce contraction.

  • Example: Endothelin-1 is released by damaged endothelial cells and is a potent vasoconstrictor.

Platelet Plug Formation

Platelets adhere to exposed collagen at the injury site, facilitated by von Willebrand Factor (vWF), and become activated to recruit more platelets.

  • Adhesion: Platelets bind to vWF attached to exposed collagen.

  • Activation: Platelets release ADP, attracting additional platelets.

  • Aggregation: Platelets bind to each other via glycoprotein receptors (e.g., GPIIb/IIIa).

  • Example: Aspirin inhibits platelet activation by blocking thromboxane A2 synthesis.

Coagulation Cascade

The coagulation cascade involves a series of enzymatic reactions that convert inactive clotting factors to their active forms, ultimately forming a fibrin mesh.

  • Intrinsic Pathway: Initiated by damage inside the vessel; involves Factors XII, XI, IX, VIII.

  • Extrinsic Pathway: Triggered by external trauma; involves Factor VII and tissue factor.

  • Common Pathway: Both pathways converge at Factor X, leading to fibrin formation.

  • Equation:

  • Example: Hemophilia A is caused by deficiency of Factor VIII (intrinsic pathway).

Clot Retraction and Dissolution

After clot formation, platelets contract to bring vessel edges closer, and the clot is eventually dissolved by fibrinolytic mechanisms.

  • Clot Retraction: Platelets contract, expelling serum and stabilizing the clot.

  • Clot Dissolution: Plasminogen is converted to plasmin, which digests fibrin.

  • Regulation: Protein C and S deactivate clotting factors to prevent excessive clotting.

  • Equation:

Hemostasis Disorders

Classification of Disorders

Hemostatic disorders are classified based on whether they primarily affect platelets or coagulation factors, and whether they increase the risk of bleeding or thrombosis.

  • Platelet-related Disorders: Affect platelet number or function.

  • Coagulation-related Disorders: Affect clotting factor activity.

  • Risk: Disorders may predispose to bleeding (hypocoagulability) or thrombosis (hypercoagulability).

Clotting (Thrombotic) Disorders

Platelet-related Clotting Disorders

  • Increased Platelet Activation: Conditions like hypertension and atherosclerosis cause arterial thrombosis.

  • Thrombocytosis: Elevated platelet count due to polycythemia vera, cancer, or chronic inflammation.

  • Example: Arterial clots are common in high-flow vessels with turbulent blood flow.

Coagulation-related Clotting Disorders

  • Genetic Mutations: Factor V Leiden (resistant to Protein C), Prothrombin gene mutation (excess prothrombin).

  • Deficiencies: Protein C & S, antithrombin deficiencies increase clot risk.

  • Antiphospholipid Syndrome: Autoantibodies increase coagulation activity, often causing venous clots.

Bleeding Disorders

Platelet-related Bleeding Disorders

  • Thrombocytopenia: Low platelet count due to decreased production (bone marrow failure), increased destruction (splenism, immune-mediated).

  • Platelet Dysfunction: von Willebrand disease, uremia (renal failure), drug-induced (antiplatelet agents).

  • Example: Aspirin and other OTC medications can impair platelet function.

Coagulation-related Bleeding Disorders

  • Deficiencies: Hemophilia (Factor VIII or IX deficiency), von Willebrand disease (also affects coagulation).

  • Disseminated Intravascular Coagulation (DIC): Widespread activation of coagulation leads to microthrombi, rapid depletion of platelets and factors, and subsequent bleeding.

  • Causes of DIC: Trauma, severe infections.

Laboratory Assessment of Hemostasis

Key Laboratory Tests

Laboratory tests help diagnose and monitor hemostatic disorders by measuring platelet count and coagulation factor activity.

Test

Purpose

Normal Range

Platelet Count

Quantifies platelets

150,000–400,000/μL

PT (Prothrombin Time)

Assesses extrinsic/common pathway

11–13 seconds

aPTT (Activated Partial Thromboplastin Time)

Assesses intrinsic/common pathway

21–35 seconds

INR (International Normalized Ratio)

Standardizes PT results

0.8–1.2

D-dimer

Detects fibrin degradation products

<0.5 μg/mL

Additional info: D-dimer is elevated in conditions with increased clot breakdown, such as DIC or deep vein thrombosis.

Treatment Overview

Coagulation Disorders

  • Fresh Frozen Plasma (FFP): Contains all coagulation factors.

  • Cryoprecipitate: Rich in fibrinogen, vWF, Factor VIII.

  • Prothrombin Complex Concentrate (PCC): Contains Factors II, VII, IX, X.

Bleeding Disorders

  • Platelet Transfusion: Used for severe thrombocytopenia.

  • Factor Replacement: Specific factor concentrates for hemophilia or vWF disease.

Additional info: Management depends on the underlying cause and severity of the disorder.

Pearson Logo

Study Prep